Sona's Cancer Therapy Creates a Systemic Immune Response in Murine Breast Cancer Model Technology Investing
Sona Nanotech Secures Grant Funding to Support Intellectual Property Strategy and Development Technology Investing
Sona Nanotech Closes Private Placement Financing to Raise $750,000 in Gross Proceeds and Announces Additional Financing Emerging Technology Investing
Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study Nanoscience Investing
